FI970959A - Virusten vastaisia nukleosidianalogeja, jotka sisältävät substituoidun bentsimidatsoliemäksen karbosykliseen renkaaseen liittyneenä - Google Patents

Virusten vastaisia nukleosidianalogeja, jotka sisältävät substituoidun bentsimidatsoliemäksen karbosykliseen renkaaseen liittyneenä Download PDF

Info

Publication number
FI970959A
FI970959A FI970959A FI970959A FI970959A FI 970959 A FI970959 A FI 970959A FI 970959 A FI970959 A FI 970959A FI 970959 A FI970959 A FI 970959A FI 970959 A FI970959 A FI 970959A
Authority
FI
Finland
Prior art keywords
carbocyclic ring
nucleoside analogs
substituted benzimidazole
analogs containing
antiviral nucleoside
Prior art date
Application number
FI970959A
Other languages
English (en)
Swedish (sv)
Other versions
FI970959A0 (fi
Inventor
Leroy B Townsend
Susan Mary Daluge
Original Assignee
Wellcome Found
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/304,006 external-priority patent/US5534535A/en
Application filed by Wellcome Found, Univ Michigan filed Critical Wellcome Found
Publication of FI970959A0 publication Critical patent/FI970959A0/fi
Publication of FI970959A publication Critical patent/FI970959A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI970959A 1994-09-09 1997-03-06 Virusten vastaisia nukleosidianalogeja, jotka sisältävät substituoidun bentsimidatsoliemäksen karbosykliseen renkaaseen liittyneenä FI970959A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/304,006 US5534535A (en) 1992-03-09 1994-09-09 Therapeutic nucleosides
PCT/US1995/011366 WO1996007646A1 (en) 1994-09-09 1995-09-11 Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring

Publications (2)

Publication Number Publication Date
FI970959A0 FI970959A0 (fi) 1997-03-06
FI970959A true FI970959A (fi) 1997-05-06

Family

ID=23174626

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970959A FI970959A (fi) 1994-09-09 1997-03-06 Virusten vastaisia nukleosidianalogeja, jotka sisältävät substituoidun bentsimidatsoliemäksen karbosykliseen renkaaseen liittyneenä

Country Status (17)

Country Link
EP (1) EP0779885A1 (fi)
JP (1) JPH10505092A (fi)
CN (1) CN1164855A (fi)
AP (1) AP741A (fi)
AU (1) AU3692895A (fi)
BR (1) BR9508826A (fi)
CA (1) CA2199502A1 (fi)
CZ (1) CZ71297A3 (fi)
FI (1) FI970959A (fi)
HU (1) HUT77440A (fi)
IS (1) IS4436A (fi)
NO (1) NO971070L (fi)
NZ (1) NZ294095A (fi)
OA (1) OA10601A (fi)
PL (1) PL319440A1 (fi)
SK (1) SK29197A3 (fi)
WO (1) WO1996007646A1 (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5912356A (en) * 1995-09-11 1999-06-15 Glaxo Wellcome Inc. Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring
GB9600142D0 (en) * 1996-01-05 1996-03-06 Wellcome Found Chemical compounds
EP0970100B1 (en) 1997-02-13 2003-11-12 Glaxo Group Limited Benzimidazole derivatives
WO1999006424A1 (en) 1997-07-30 1999-02-11 The Regents Of The University Of Michigan Lyxofuranosyl benzimidazoles as antiviral agents
US6770666B2 (en) 1999-12-27 2004-08-03 Japan Tobacco Inc. Fused-ring compounds and use thereof as drugs
CA2363274A1 (en) 1999-12-27 2001-07-05 Japan Tobacco Inc. Fused-ring compounds and use thereof as drugs for hepatitis c
GB0008939D0 (en) 2000-04-11 2000-05-31 Glaxo Group Ltd Process for preparing substituted benzimidazole compounds
AR035543A1 (es) * 2001-06-26 2004-06-16 Japan Tobacco Inc Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
CN1834090B (zh) * 2005-03-18 2011-06-29 中国科学院上海药物研究所 苯并咪唑类化合物、其制备方法以及用途
ES2758027T3 (es) 2007-08-02 2020-05-04 Millennium Pharm Inc Intermedios para la síntesis de inhibidores de enzimas activadoras de actividad E1

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9205071D0 (en) * 1992-03-09 1992-04-22 Wellcome Found Therapeutic nucleosides

Also Published As

Publication number Publication date
FI970959A0 (fi) 1997-03-06
JPH10505092A (ja) 1998-05-19
PL319440A1 (en) 1997-08-04
NO971070D0 (no) 1997-03-07
CZ71297A3 (en) 1997-08-13
NO971070L (no) 1997-05-07
HUT77440A (hu) 1998-04-28
WO1996007646A1 (en) 1996-03-14
CA2199502A1 (en) 1996-03-14
AP741A (en) 1999-04-26
MX9701789A (es) 1997-10-31
AU3692895A (en) 1996-03-27
BR9508826A (pt) 1997-09-30
NZ294095A (en) 1998-08-26
SK29197A3 (en) 1997-10-08
AP9700940A0 (en) 1997-04-30
IS4436A (is) 1997-03-07
EP0779885A1 (en) 1997-06-25
CN1164855A (zh) 1997-11-12
OA10601A (en) 2002-09-03

Similar Documents

Publication Publication Date Title
PT526253E (pt) Analogos do nucleosido 1,3-oxatiolano
ATE44464T1 (de) Antivirale nukleoside.
DK0379147T3 (da) Ekstruderbare, elastiske geler til anvendelse som bærermateriale for terapeutisk middel
DE3485225D1 (de) Antivirale guanin-derivate.
DK0915819T3 (da) Illudinanaloger anvendt som antitumormiddel
FI970959A0 (fi) Virusten vastaisia nukleosidianalogeja, jotka sisältävät substituoidun bentsimidatsoliemäksen karbosykliseen renkaaseen liittyneenä
ES523075A0 (es) Procedimiento para la obtencion de un catalizador a base de gamma alumina.
NO864987D0 (no) Heteroaromatiske acetylener brukbare som antihypertensive midler.
NO995620D0 (no) Antivirale kombinasjoner inneholdende karbocyklisk nukleosid 1592U89
IT1188659B (it) Analoghi di prostaglandine 7-ossabicicloeptano sostituiti
NO954399D0 (no) 8-substituerte xanthiner som selektive adenosinreseptormidler
IT1227906B (it) Nuovo procedimento per la sintesi della n alfa -fluorenilmetossicar bonil-n(elevato a g)- tritil-arginina
FI875463A0 (fi) Koncentrerade emulgerbara herbicidkoncentrationer som baserar sig pao meta-biskarbamat.
NO301539B1 (no) Oralt aktive, antivirale forbindelser
KR880003089U (ko) 파이커, 엘리트용 도트클락 발생회로
FIU970397U0 (fi) Katamaraaniksi yhdistyvät kajakit
IT8553540V0 (it) Dispositivo di attacco del manubrio per biciclette
BR8506410A (pt) Porta bicicletas
IT8559333V0 (it) Struttura di palla,particolarmente per impieghi medico-sportivi
SE8503116D0 (sv) Skyddshuv till ledkula
IT8523382V0 (it) Lampada portatile per uso individuale applicabile al capo.
ES294840Y (es) Soporte para sillin de bicicleta, perfeccionando
IT207921Z2 (it) Elemento tubolare con tappo amovibile per derivare condutture di utilizzazione da condotte di adduzione di fluidi particolarmente gas combu
ATE58736T1 (de) Guaninderivate.
IT209060Z2 (it) Struttura di ruota particolarmente per motocicli di alte prestazioni.